What "peptide therapy" actually means

A peptide is a length, not a kind of medicine

A peptide is a short chain of amino acids. That is the entire definition. Chain them further and the same material is called a protein. The boundary between the two words is a matter of convention rather than a real line in chemistry.

Nothing in that definition says anything about what a molecule does, whether it works, whether it is safe, or whether it is legal to sell. Amino acid chains are how the body writes most of its own signals. So calling a compound a peptide places it in a category that includes hormones, immune signals, digestive regulators and structural fragments, with nothing in common except their construction.

This is worth being blunt about, because the word is doing persuasive work it has not earned. 'Peptide' sounds specific and biological and precise. It is closer to saying a product is 'made of molecules'.

Some of the most rigorously tested drugs in medicine are peptides

The argument that peptides are unproven fringe medicine is as wrong as the argument that peptides are proven because peptides are natural. Insulin is a peptide. Semaglutide and tirzepatide are peptides. So are tesamorelin, teriparatide, leuprolide, octreotide and bremelanotide. All of them have approved products in the United States, all are supported by controlled trials, and all are prescribed with a reviewed label attached.

So a clinic saying 'peptides are used throughout modern medicine' is telling the truth. The sentence is simply not evidence for anything on its menu. Insulin's trial record does not transfer to a compound that shares nothing with it but a structural class.

The useful consequence is that class-level arguments in either direction should be discarded on sight. Nobody should accept or reject a compound because it is a peptide. The only question that carries information is what has been shown about that specific compound, for that specific use, in people resembling the person buying it.

What a peptide therapy clinic is usually selling

Behind the category word, the commercial offering is fairly consistent. There is a consultation, usually remote. There are often lab tests. There is a prescription for a compounded preparation, generally supplied as a subcutaneous injection, and often a recurring supply arrangement.

The compounds themselves fall into a few groups. The largest by volume is the growth hormone axis: sermorelin most of all, plus compounds such as CJC-1295 and ipamorelin. All of those work by prompting the body to release its own growth hormone rather than by supplying a hormone directly. Alongside them sit metabolic and coenzyme products, of which NAD+ and its precursors are the main example. Then there is a repair-and-recovery group — compounds such as BPC-157 and TB-500 — and a cosmetic and general anti-aging group including GHK-Cu. Sexual function is usually represented by PT-141.

Those groups have very different evidence behind them, and the menu does not signal that. The compounds are presented in the same typeface at comparable prices with comparable confidence, which is precisely the flattening this site exists to undo.

Three supply channels that are easy to confuse and are not the same

The single most practically useful distinction in this whole category is not about molecules. It is about where a product came from.

An FDA-approved drug has been reviewed for safety, effectiveness and manufacturing quality. It comes with a label describing what it does, who it is for and what goes wrong. Approval attaches to a specific product for a specific indication in a specific population, not to a chemical formula. That is why the same molecule can be rigorously evidenced in one context and entirely unevidenced in another.

A compounded preparation is made by a pharmacy, and it has not been reviewed by the FDA for safety, effectiveness or manufacturing quality. That is a statement about the pathway, not an accusation about any given pharmacy, many of which are licensed, inspected and careful. It is a real distinction nonetheless, and it is the one most often blurred by the phrase 'prescribed by a doctor'.

Material sold in vials labeled for research use only is a third thing entirely. It is not a prescription product and not a compounded one. It sits outside the drug supply chain, with no assurance attached about identity, purity, sterility or how much of the labeled compound is actually in the vial. A significant amount of what people call peptide therapy is bought this way, and the difference between that and a pharmacy preparation is not a formality.

Where the regulatory question sits

When no approved product exists for a substance, whether it may lawfully be compounded is governed by a bulk drug substances framework that is being worked out substance by substance. This site dates what is on the record and predicts nothing about what is not. So no compound's status, vote or outcome is named here. Each compound's dated status record is where that belongs.

One thing can be said plainly. A reader should not take the availability of something as evidence that its position is settled. Availability and legal clarity are separate facts, and in this category they come apart routinely.

This page describes how the category is organized. It carries no dosing information and is not usage guidance.

One grade cannot cover this category

The evidence grade here is limited, and it needs an explicit caveat, because a single grade across a category containing insulin would be meaningless.

It applies to the compounded peptide therapy menu as it is actually sold: the growth-hormone-axis and coenzyme products that make up most of what clinics prescribe, whose most common item is sermorelin. Limited evidence in these tiers means a real, mechanistically supported effect with thin long-term outcome data. That is a fair description of the center of that menu.

It does not describe the whole menu. Several compounds routinely sold alongside those carry the lowest tier, no controlled human evidence, and grading the category at limited would overstate them. Nor does it describe the approved peptide drugs, which sit at the top tier and are not what a wellness clinic is generally selling.

So the honest instruction is to ignore the category grade and read the compound. This site assigns an evidence grade per compound for exactly this reason. The number of tiers a single clinic menu can span is itself the most important thing to know about peptide therapy.

A short test to apply to any peptide claim

Three questions separate a supported claim from a plausible one, and none of them require any technical background.

First: what exactly was measured? A hormone level rising is not the same as a person feeling or functioning better, and the peptide market leans heavily on markers because markers are cheap to move and cheap to demonstrate.

Second: in whom? Evidence generated in a specific patient population does not extend to a healthy adult buying the same molecule for a different reason. Population is part of a finding, not a detail attached to it.

Third: compared with what? Without a control group, any intervention accompanied by attention, expectation and a decision to take one's health seriously will produce reported improvement. That is not a criticism of the people reporting it. It is the reason controlled trials were invented.